William M. Clancy
Known title: Exec. VP/CFOCIK: 0001228016
Associated companies
Transaction History
| VPG | ▲ Buy | Grant | 5,517 | $0 | 2/26/2026 | View on chart |
| VPG | ▼ Sell | Tax Withholding | 1,643 | $63K | 1/1/2026 | View on chart |
| VPG | ▲ Buy | Grant | 6,723 | $0 | 2/24/2025 | View on chart |
| VPG | ▼ Sell | Tax Withholding | 1,442 | $34K | 1/1/2025 | View on chart |
| VPG | ▲ Buy | Grant | 4,547 | $0 | 3/6/2024 | View on chart |
| VPG | ▼ Sell | Tax Withholding | 2,100 | $72K | 2/28/2024 | View on chart |
| VPG | ▲ Buy | Grant | 4,540 | — | 2/28/2024 | View on chart |
| VPG | ▼ Sell | Tax Withholding | 1,887 | $64K | 1/1/2024 | View on chart |
| VPG | ▼ Sell | Open Market | 6,000 | $270K | 3/1/2023 | View on chart |
| VPG | ▼ Sell | Tax Withholding | 2,512 | $110K | 2/28/2023 | View on chart |
| VPG | ▲ Buy | Grant | 3,955 | $0 | 2/28/2023 | View on chart |
| VPG | ▲ Buy | Grant | 5,207 | — | 2/28/2023 | View on chart |
| VPG | ▼ Sell | Tax Withholding | 845 | $33K | 1/1/2023 | View on chart |
| VPG | ▲ Buy | Grant | 2,505 | — | 3/3/2022 | View on chart |
| VPG | ▲ Buy | Grant | 3,944 | $0 | 3/3/2022 | View on chart |
| VPG | ▼ Sell | Tax Withholding | 1,147 | $35K | 3/3/2022 | View on chart |
| VPG | ▼ Sell | Tax Withholding | 1,012 | $38K | 1/1/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
Jim Cramer Names VPG a Health Care Winner
Jim Cramer highlighted Vishay Precision Group as a health‑care winner in a recent Benzinga interview. The comment may raise interest among investors looking for strong performers in the medical device sector. VPG trades near its 52‑week low and its RSI suggests it is not yet overbought. The endorsement could add to the stock’s visibility.
Jim Cramer Names VPG a Health Care Winner. Jim Cramer highlighted Vishay Precision Group as a health‑care winner in a recent Benzinga interview. The comment may raise interest among investors looking for strong performers in the medical device sector. VPG trades near its 52‑week low and its RSI suggests it is not yet overbought. The endorsement could add to the stock’s visibility.